Cargando…

ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia

COVID-19 has changed the nature of medical consultations, emphasizing virtual patient counselling, with relevance for patients with diabetes insipidus (DI) or hyponatraemia. The main complication of desmopressin treatment in DI is dilutional hyponatraemia. Since plasma sodium monitoring is not alway...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christ-Crain, Mirjam, Hoorn, Ewout J, Sherlock, Mark, Thompson, Chris J, Wass, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Practice Guidance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428073/ https://www.ncbi.nlm.nih.gov/pubmed/34292875 http://dx.doi.org/10.1530/EJE-21-0596

Ejemplares similares

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2020)

SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus
por: Baldeweg, S E, et al.
Publicado: (2018)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of severe symptomatic hyponatraemia in adult patients
por: Ball, Stephen, et al.
Publicado: (2016)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation
por: Wake, Deborah J, et al.
Publicado: (2020)

Endocrinology in the time of COVID-19: Management of pituitary tumours
por: Fleseriu, Maria, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
por: Newell-Price, John, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism
por: Boelaert, Kristien, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
por: Arlt, Wiebke, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis
por: Gittoes, Neil J, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus
por: Thangaratinam, Shakila, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
por: Vrachimis, Alexis, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
por: Casey, Ruth T, et al.
Publicado: (2020)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients
por: Baldeweg, Stephanie E, et al.
Publicado: (2016)

Updated clinical management guidance during the COVID-19 pandemic: thyroid nodules and cancer
por: Giannoula, Evanthia, et al.
Publicado: (2022)

Update: use of the benchmark dose approach in risk assessment
por: Hardy, Anthony, et al.
Publicado: (2017)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
por: Higham, C E, et al.
Publicado: (2018)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients
por: Walsh, Jennifer, et al.
Publicado: (2016)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypocalcaemia in adult patients
por: Turner, Jeremy, et al.
Publicado: (2016)

SIADH and hyponatraemia: why does it matter?
por: Hoorn, Ewout J., et al.
Publicado: (2009)

Update: methodological principles and scientific methods to be taken into account when establishing Reference Points for Action (RPAs) for non‐allowed pharmacologically active substances present in food of animal origin
por: Knutsen, Helle Katrine, et al.
Publicado: (2018)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
por: Fontana, Robert J., et al.
Publicado: (2023)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients
por: Arlt, Wiebke
Publicado: (2016)

Guidance on the assessment criteria for applications for new or modified stunning methods regarding animal protection at the time of killing
por: More, Simon, et al.
Publicado: (2018)

Hyponatraemia in patients on immune checkpoint inhibitors
por: Paschou, Stavroula A., et al.
Publicado: (2022)

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus
por: Arima, Hiroshi, et al.
Publicado: (2022)

Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
por: Arima, Hiroshi, et al.
Publicado: (2022)

Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp)
por: Vernooij, Robin W. M., et al.
Publicado: (2017)

Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1)
por: Turck, Dominique, et al.
Publicado: (2021)

Scientific Guidance on the data required for the risk assessment of flavourings to be used in or on foods
por: Younes, Maged, et al.
Publicado: (2022)

Guidance on the preparation and submission of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 (Revision 1)(2)
por: Nutrition,, et al.
Publicado: (2021)

Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
por: Arima, Hiroshi, et al.
Publicado: (2022)

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus
por: Arima, Hiroshi, et al.
Publicado: (2023)

Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
por: Refardt, Julie, et al.
Publicado: (2019)

UK’s initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals
por: Chilcott, Robert P, et al.
Publicado: (2019)

Guidance on dermal absorption
por: Buist, Harrie, et al.
Publicado: (2017)

Reporting data on pesticide residues in food and feed according to Regulation (EC) No 396/2005 (2016 data collection)
por: Brancato, Alba, et al.
Publicado: (2017)

Guidance on the identity, characterisation and conditions of use of feed additives
por: Rychen, Guido, et al.
Publicado: (2017)

Guidance on quantitative pest risk assessment
por: Jeger, Michael, et al.
Publicado: (2018)

Guidance on the assessment of the safety of feed additives for the consumer
por: Rychen, Guido, et al.
Publicado: (2017)

Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health
por: Hardy, Anthony, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gvfm115vi7u1s8pjh0admvepj6